Use access key #2 to skip to page content.
$72.74 -0.29 (-0.40%)
11/21/2008 4:01 PM

Genentech, Inc. (DNA)

CAPS Rating:
*****

The Company is a biotechnology company that discovers, develops, manufactures, and commercializes biotherapeutics for unmet medical needs.

View All Commentary (DNA)

Recs

0

Avatar sundse (86.99) Submitted: 12/07/07 1:19 PM : Outperform Start Price: $68.16 DNA Score: 56.46

I like their CEO who seems very sharp. I like the emphasis on autoimmune disease and both basic research in this field and targeted drug development.

They have a good P/E (26) for their projected growth.

Report this Post Replies: 0 | Reply | Permalink

Featured Broker Partners

Sponsored Links